EP3481864 - ANTI-APOC3 ANTIBODIES AND METHODS OF USE THEREOF [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 17.05.2024 Database last updated on 22.08.2024 | |
Former | Examination is in progress Status updated on 10.07.2020 | ||
Former | Request for examination was made Status updated on 12.04.2019 | ||
Former | The international publication has been made Status updated on 12.01.2018 | ||
Former | unknown Status updated on 09.08.2017 | Most recent event Tooltip | 17.05.2024 | Application deemed to be withdrawn | published on 19.06.2024 [2024/25] | Applicant(s) | For all designated states Staten Biotechnology B.V. Transistorweg 5J 6534 AT Nijmegen / NL | [2019/20] | Inventor(s) | 01 /
DASILVA-JARDINE, Paul 160 Sam Hill Road Gilford, Connecticut 06437 / US | 02 /
DE HAARD, Hans 't Zwint 1 NL-4436 NA Oudelande / NL | 03 /
LANDRO, James A. 412 Maple Avenue Cheshire, Connecticut 06410 / US | [2019/20] | Representative(s) | Simmons & Simmons LLP (Munich), et al Lehel Carré Thierschplatz 6 80538 Munich / DE | [N/P] |
Former [2019/20] | Lahrtz, Fritz Patentanwälte Isenbruck Bösl Hörschler PartG mbB Prinzregentenstraße 68 81675 München / DE | Application number, filing date | 17745513.6 | 07.07.2017 | [2019/20] | WO2017IB54125 | Priority number, date | US201662360084P | 08.07.2016 Original published format: US 201662360084 P | US201762491591P | 28.04.2017 Original published format: US 201762491591 P | [2019/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018007999 | Date: | 11.01.2018 | Language: | EN | [2018/02] | Type: | A1 Application with search report | No.: | EP3481864 | Date: | 15.05.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 11.01.2018 takes the place of the publication of the European patent application. | [2019/20] | Search report(s) | International search report - published on: | EP | 11.01.2018 | (Supplementary) European search report - dispatched on: | EP | 14.07.2020 | Classification | IPC: | C07K16/18, A61K39/395, A61P3/06 | [2019/20] | CPC: |
C07K16/18 (EP,KR,US);
A61K39/3955 (US);
A61K31/397 (EP,US);
A61K45/06 (KR,US);
A61P3/06 (EP,KR,US);
A61P9/00 (KR);
A61P9/10 (EP,KR,US);
C12N15/63 (US);
C12N5/00 (US);
A61K2039/505 (EP,KR,US);
C07K14/775 (US);
C07K2317/22 (EP,KR,US);
C07K2317/24 (US);
C07K2317/33 (EP,KR,US);
C07K2317/34 (EP,KR,US);
C07K2317/51 (US);
C07K2317/56 (US);
C07K2317/565 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/20] | Extension states | BA | 07.02.2019 | ME | 07.02.2019 | Validation states | MA | 07.02.2019 | MD | 07.02.2019 | Title | German: | ANTI-APOC3-ANTIKÖRPER UND VERFAHREN ZUR VERWENDUNG DAVON | [2019/20] | English: | ANTI-APOC3 ANTIBODIES AND METHODS OF USE THEREOF | [2019/20] | French: | ANTICORPS ANTI-APOC3 ET LEURS MÉTHODES D'UTILISATION | [2019/20] | Entry into regional phase | 07.02.2019 | National basic fee paid | 07.02.2019 | Designation fee(s) paid | 07.02.2019 | Examination fee paid | Examination procedure | 07.02.2019 | Examination requested [2019/20] | 07.02.2019 | Date on which the examining division has become responsible | 29.08.2019 | Amendment by applicant (claims and/or description) | 14.07.2020 | Despatch of a communication from the examining division to which search results under Rule 164(2) EPC are annexed (Time limit: M08) [2020/33] | 14.07.2020 | Despatch of a communication from the examining division (Time limit: M08) | 30.06.2021 | Reply to a communication from the examining division | 23.12.2021 | Despatch of a communication from the examining division (Time limit: M04) | 13.04.2022 | Reply to a communication from the examining division | 01.02.2024 | Application deemed to be withdrawn, date of legal effect [2024/25] | 21.02.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2024/25] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 30.06.2021 | Request for further processing filed | 30.06.2021 | Full payment received (date of receipt of payment) Request granted | 12.07.2021 | Decision despatched | Fees paid | Renewal fee | 15.07.2019 | Renewal fee patent year 03 | 14.07.2020 | Renewal fee patent year 04 | 27.07.2021 | Renewal fee patent year 05 | 27.07.2022 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 31.07.2023 | 07   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XI]WO2004081046 (GLAXOSMITHKLINE BIOLOG SA [BE], et al) [X] 1-5 * page 7, line 5 - line 16 * * page 15, line 13 - line 25 * [I] 6,7,41-64; | [A]WO2004097429 (BIOSTRATUM INC [US], et al) [A] 1-7,41-64* page 8, line 13 - line 32; claim 5 *; | [XI]WO2014131008 (INTRINSIC METABIO SOLUTIONS LLC [US]) [X] 1-5 * examples 1,2 * * page 1, line 15 - line 23 * [I] 6,7,41-64 | by applicant | US4044126 | US4364923 | US4414209 | US4444887 | WO8605807 | EP0239400 | US4716111 | WO8901036 | US4816567 | US4816397 | WO9002809 | WO9109967 | WO9110737 | WO9110741 | WO9201047 | US5122464 | WO9218619 | WO9222324 | EP0519596 | WO9311236 | US5223409 | US5225539 | WO9317105 | WO9404678 | EP0592106 | WO9425591 | US5403484 | US5413923 | WO9515982 | US5427908 | WO9520401 | US5516637 | US5530101 | US5545806 | US5565332 | US5569825 | WO9634096 | WO9633735 | US5571698 | US5580717 | US5585089 | WO9713844 | US5625126 | US5633425 | US5658727 | US5661016 | US5698426 | US5709874 | US5733743 | WO9816654 | US5750753 | US5759542 | WO9824893 | US5766886 | US5780225 | US5807715 | US5814318 | US5821047 | WO9846645 | WO9850433 | US5837242 | US5840674 | US5860957 | US5869620 | US5885793 | US5900252 | US5939598 | US5948433 | US5965726 | US5969108 | US5972366 | US5983134 | US5985317 | US5985307 | US5989830 | US6004534 | US6005079 | US6010715 | US6024975 | US6039975 | US6048736 | US6060082 | US6071495 | US6075181 | US6120751 | US6131570 | US6132992 | US6139865 | US6150184 | US6167301 | US6174666 | WO0144301 | US6256533 | US6253872 | US6261595 | US6267983 | US6271359 | US6274552 | US6291664 | US6316652 | US6331415 | US6407213 | US6414132 | US6794498 | US2005042664 | US2005048549 | US7183076 | US7709226 | US7951917 | US8227577 | US8586713 | - KABAT et al., J. Biol. Chem., (19770000), vol. 252, pages 6609 - 6616 | - CHOTHIA et al., J. Mol. Biol., (19870000), vol. 196, pages 901 - 917 | - MACCALLUM et al., J. Mol. Biol., (19960000), vol. 262, pages 732 - 745 | - CHOTHIA C; LESK AM, J Mol Biol, (19870000), vol. 196, pages 901 - 917 | - AL-LAZIKANI B et al., J Mol Biol, (19970000), vol. 273, pages 927 - 948 | - CHOTHIA C et al., J Mol Biol, (19920000), vol. 227, pages 799 - 817 | - TRAMONTANO A et al., J Mol Biol, (19900000), vol. 215, no. 1, pages 175 - 182 | - LEFRANC M-P, The Immunologist, (19990000), vol. 7, pages 132 - 136 | - LEFRANC M-P et al., Nucleic Acids Res, (19990000), vol. 27, pages 209 - 212 | - MACCALLUM RM et al., J Mol Biol, (19960000), vol. 262, pages 732 - 745 | - "Protein Sequence and Structure Analysis of Antibody Variable Domains", MARTIN A., Antibody Engineering, Springer-Verlag, (20010000), pages 422 - 439 | - STAHLI C et al., Methods Enzymol, (19830000), vol. 9, pages 242 - 253 | - KIRKLAND TN et al., J Immunol, (19860000), vol. 137, pages 3614 - 3619 | - MOREL GA et al., Mol Immunol, (19880000), vol. 25, no. 1, pages 7 - 15 | - CHEUNG RC et al., Virology, (19900000), vol. 176, pages 546 - 552 | - MOLDENHAUER G et al., Scand J Immunol, (19900000), vol. 32, pages 77 - 82 | - WAGENER C et al., J Immunol, (19830000), vol. 130, pages 2308 - 2315 | - WAGENER C et al., J Immunol Methods, (19840000), vol. 68, pages 269 - 274 | - KUROKI M et al., Cancer Res, (19900000), vol. 50, pages 4872 - 4879 | - KUROKI M et al., Immunol Invest, (19920000), vol. 21, pages 523 - 538 | - KUROKI M et al., Hybridoma, (19920000), vol. 11, pages 391 - 407 | - Antibodies: A Laboratory Manual, pages 386 - 389 | - KUTMEIER G et al., BioTechniques, (19940000), vol. 17, pages 242 - 246 | - Current Protocols in Molecular Biology, Green Publishing Associates, Inc. and John Wiley & Sons, Inc., (19890000), vol. I, pages 6.3.1 - 6.3.6,2.10.3 | - FOECKING MK; HOFSTETTER H, Gene, (19860000), vol. 45, pages 101 - 105 | - COCKETT MI et al., Biotechnology, (19900000), vol. 8, no. 7, pages 662 - 667 | - RUETHER U; MUELLER-HILL B, EMBO J, (19830000), vol. 2, pages 1791 - 1794 | - INOUYE S; INOUYE M, Nuc Acids Res, (19850000), vol. 13, pages 3101 - 3109 | - VAN HEEKE G; SCHUSTER SM, J Biol Chem, (19890000), vol. 24, pages 5503 - 5509 | - LOGAN J; SHENK T, PNAS, (19840000), vol. 81, no. 12, pages 3655 - 3659 | - BITTER G et al., Methods Enzymol., (19870000), vol. 153, pages 516 - 544 | - WIGLER M et al., Cell, (19770000), vol. 11, no. 1, pages 223 - 232 | - SZYBALSKA EH; SZYBALSKI W, PNAS, (19620000), vol. 48, no. 12, pages 2026 - 2034 | - LOWY I et al., Cell, (19800000), vol. 22, no. 3, pages 817 - 823 | - WIGLER M et al., PNAS, (19800000), vol. 77, no. 6, pages 3567 - 3570 | - O'HARE K et al., PNAS, (19810000), vol. 78, pages 1527 - 1531 | - MULLIGAN RC; BERG P, PNAS, (19810000), vol. 78, no. 4, pages 2072 - 2076 | - WU GY; WU CH, Biotherapy, (19910000), vol. 3, pages 87 - 95 | - TOLSTOSHEV P, Ann Rev Pharmacol Toxicol, (19930000), vol. 32, pages 573 - 596 | - MULLIGAN RC, Science, (19930000), vol. 260, pages 926 - 932 | - MORGAN RA; ANDERSON WF, Ann Rev Biochem, (19930000), vol. 62, pages 191 - 217 | - NABEL GJ; FEIGNER PL, Trends Biotechnol, (19930000), vol. 11, no. 5, pages 211 - 215 | - SANTERRE RF et al., Gene, (19840000), vol. 30, no. 1-3, pages 147 - 156 | - COLBERE-GARAPIN F et al., J Mol Biol, (19810000), vol. 150, pages 1 - 14 | - BEBBINGTON CR; HENTSCHEL CCG, The use of vectors based on gene amplification for the expression of cloned genes in mammalian cells in DNA cloning, Academic Press, (19870000), vol. 3 | - CROUSE GF et al., Mol Cell Biol, (19830000), vol. 3, pages 257 - 266 | - PROUDFOOT NJ, Nature, (19860000), vol. 322, pages 562 - 565 | - KOHLER G, PNAS, (19800000), vol. 77, pages 2197 - 2199 | - HAMMERLING GJ et al., Monoclonal Antibodies and T-Cell Hybridomas, Elsevier, (19810000), pages 563 - 681 | - KOHLER G; MILSTEIN C, Nature, (19750000), vol. 256, page 495 | - Monoclonal Antibodies: Principles and Practice, Academic Press, (19860000), pages 59 - 103 | - KILPATRICK KE et al., Hybridoma, (19970000), vol. 16, pages 381 - 389 | - KOZBOR D, J Immunol, (19840000), vol. 133, pages 3001 - 3005 | - BRODEUR et al., Monoclonal Antibody Production Techniques and Applications, Marcel Dekker, Inc., (19870000), pages 51 - 63 | - Monoclonal Antibodies: Principles and Practice | - BRINKMAN U et al., J Immunol Methods, (19950000), vol. 182, pages 41 - 50 | - AMES RS et al., J Immunol Methods, (19950000), vol. 184, pages 177 - 186 | - KETTLEBOROUGH CA et al., Eur J Immunol, (19940000), vol. 24, pages 952 - 958 | - PERSIC L et al., Gene, (19970000), vol. 187, pages 9 - 18 | - BURTON DR; BARBAS CF, Advan Immunol, (19940000), vol. 57, pages 191 - 280 | - MULLINAX RL et al., BioTechniques, (19920000), vol. 12, no. 6, pages 864 - 869 | - SAWAI H et al., Am J Reprod Immunol, (19950000), vol. 34, pages 26 - 34 | - BETTER M et al., Science, (19880000), vol. 240, pages 1041 - 1043 | - MORRISON SL, Science, (19850000), vol. 229, pages 1202 - 1207 | - OI VT; MORRISON SL, BioTechniques, (19860000), vol. 4, pages 214 - 221 | - GILLIES SD et al., J Immunol Methods, (19890000), vol. 125, pages 191 - 202 | - PADLAN EA, Mol Immunol, (19910000), vol. 28, no. 4/5, pages 489 - 498 | - STUDNICKA GM et al., Prot Engineering, (19940000), vol. 7, no. 6, pages 805 - 814 | - ROGUSKA MA et al., PNAS, (19940000), vol. 91, pages 969 - 973 | - TAN P et al., J Immunol, (20020000), vol. 169, pages 1119 - 1125 | - CALDAS C et al., Protein Eng., (20000000), vol. 13, no. 5, pages 353 - 360 | - MOREA V et al., Methods, (20000000), vol. 20, no. 3, pages 267 - 279 | - BACA M et al., J Biol Chem, (19970000), vol. 272, no. 16, pages 10678 - 10684 | - ROGUSKA MA et al., Protein Eng, (19960000), vol. 9, no. 10, pages 895 - 904 | - COUTO JR et al., Cancer Res., (19950000), vol. 55, no. 23, pages 5973s - 5977s | - COUTO JR et al., Cancer Res, (19950000), vol. 55, no. 8, pages 1717 - 1722 | - SANDHU JS, Gene, (19940000), vol. 150, no. 2, pages 409 - 410 | - PEDERSEN JT et al., J Mol Biol, (19940000), vol. 235, no. 3, pages 959 - 973 | - RIECHMANN L; MUYLDERMANS S, J Immunol, (19990000), vol. 231, pages 25 - 38 | - NUTTALL SD et al., Curr Pharm Biotechnol, (20000000), vol. 1, no. 3, pages 253 - 263 | - MUYLDERMANS S, J Biotechnol, (20010000), vol. 74, no. 4, pages 277 - 302 | - GREENSPAN NS; BONA CA, FASEB J, (19890000), vol. 7, no. 5, pages 437 - 444 | - NISSINOFF A, J Immunol, (19910000), vol. 147, no. 8, pages 2429 - 2438 | - LONBERG N; HUSZAR D, Int Rev Immunol, (19950000), vol. 13, pages 65 - 93 | - SHINMOTO H et al., Cytotechnology, (20040000), vol. 46, pages 19 - 23 | - NAGANAWA Y et al., Human Antibodies, (20050000), vol. 14, pages 27 - 31 | - KLARENBEEK et al., Protein Eng Des Sel, (20160000), vol. 29, no. 4, pages 123 - 133 | - VAN DER WONING et al., "DNA immunization combined with scFv phage display identifies antagonistic GCGR specific antibodies and reveals new epitopes on the small extracellular loops", mAbs, (20160000), vol. 8, no. 6, pages 1126 - 1135 |